Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2007-09-04
2007-09-04
Gitomer, Ralph (Department: 1657)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Reexamination Certificate
active
11016545
ABSTRACT:
The present invention provides methods and systems for performing in-vivo flow cytometry to obtain desired information regarding one or more cell types of interest flowing through a subject's circulatory system. In one embodiment of the invention, a portion of the subject's circulating blood is illuminated with radiation having multiple wavelength components, and the backscattered radiation generated in response to the excitation radiation is detected at a plurality of scattering angles and analyzed to derive the desired information.
REFERENCES:
Michelson et al. Methods 2000;21:259-270.
Novak et al. Optics Letters 2004;29(1):77-79.
Momma T, Hamblin MR, Wu HC, Hasan T. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.Cancer Res1998; 58: 5425-31.
Lein M, Koenig F, Misdraji J, et al. Laser-induced hyperthermia in rat prostate cancera; role of site of tumor implantation.Urology2000; 56: 167-72.
Georgakoudi I, Solban N, Novak J, et al. In vivo flow cytometry: A new method for enumerating circulating cancer cells.Cancer Res2004; In Press.
Novak J, Georgakoudi I, Wei X, Prossin A, Lin CP. In vivo flow cytometer for real-time detection and quantification of circulating cells.Opt Lett2004; 29: 77-9.
SEER Cancer Statistics Review, 1975-2001.In: L. Ries, M. Eisner, C. Kosary, B. Hankey, B. Miller, L. Clegg, A. Mariotto, E. Feuer, and E. B. (eds). (eds.). Bethesda, MD, http://seer.cancer.gov/csr/1975 2001/: National Cancer Institute, 2004.
Bassan R, Gatta G, Tondini C, Willemze R. Adult acute lymphoblastic leukeamia.Crit Rev Onc Hematol2004; 50: 223-61.
Perelman L, Backman V, Wallace M, et al. Observation of periodic fine structure in reflectance from biological tissue: A new technique for measuring nuclear size distribution.Phys Rev Let1998; 80:627-30.
Shapiro H Practical Flow Cytometry. New York: Alan R. Liss, Inc., 1985.
Handbook of biological confocal microscopy, 2nd edition. New York: Plenum Press, 1995.
Surveillance, Epidemiology and End Results (SEER) Program. National Cancer Institute, 1975-2000.
Cancer Incidence and Survival among Children and Adolescents: United States SEER Program, 1975-1995. National Cancer Institute, 1999.
Hoffman R, Benz E, Shattil S, et al Hematology: Basic Principles and Practice. New York: Churchill Livingstone, 2000.
Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.J Clin Oncol1996; 14: 18-24.
Coustan-Smith E, Sancho J, Hancock ML, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.Blood2000; 96: 2691-6.
Krauter J, Wattjes MP, Nagel S, et al. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients.Br J Haematol1999; 107: 80-5.
Nyvold C, Madsen HO, Ryder LP, et al. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome.Blood2002; 99: 1253-8.
Cave H, van der Werff ten Bosch J, Suciu S, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia, European Organization for Research and Treatment of Cancer—Childhood Leukemia Cooperative Group.N Engl J Med1998; 339: 591-8.
Brisco MJ, Condon J, Hughes E, et al. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction.Lancet1994; 343: 196-200.
Knechtli CJ, Goulden NJ, Hancock JP, et al. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia.Blood1998; 92: 4072-9.
Ford AM, Fasching K, Panzer-Grumayer ER, Koenig M, Haas OA, Greaves MF. Origins of “late” relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes.Blood2001; 98: 558-64.
Konrad M, Metzler M, Panzer S, et al. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.Blood2003; 101: 3635-40.
Potter MN, Steward CG, Oakhill A. The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.Br J. Haematol1993; 83: 412-8.
Venditti A, Buccisano F, Del Poeta G, et al. Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia.Blood2000; 96: 3948-52.
Coustan-Smith E, Behm FG, Sanchez J, et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia.Lancet1998; 351: 550-4.
San Miguel JF, Martinez A, Macedo A, et al. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.Blood1997; 90: 2465-70.
Janossy G, Bollum FJ, Bradstock KF, Ashley J. Cellular phenotypes of normal and leukemic hemopoietic cells determined by analysis with selected antibody combinations.Blood1980; 56: 430-41.
Coustan-Smith E, Sancho J, Hancock ML, et al. Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia.Blood2002; 100: 2399-402.
Facts and Figures. National Institute of Allergy and Infectious Diseases, 2004.
Siddiqua A, Chendil D, Rowland R, et al. Increased expression of PSA mRNA during brachytherapy in peripheral blood of patients with prostate cancer. Urology 2002; 60: 270-5.
Fidler I. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited.Nature Rev Cancer2003; 3: 453-8.
Racila E, Euhus D, Weiss AJ, et al. Detection and characterization of carcinoma cells in the blood.Proc Natl Acad Sci U S A1998; 95: 4589-94.
Dubey P, Su H, Adonai N, et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography.Proc Natl Acad Sci U S A2003; 100: 1232-7.
Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging.Biophys J1999; 76: 103-9.
Naumov GN, Wilson SM, MacDonald IC, et al. Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis.J Cell Sci1999; 112: 1835-42.
Sweeney TJ, Mailander V, Tucker AA, et al. Visualizing the kinetics of tumor-cell clearance in living animals. ProcNatl Acad Sci U S A1999; 96: 12044-9.
Wang W, Wyckoff JB, Frohlich VC, et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling.Cancer Res2002; 62: 6278-88.
Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics.Science2002; 296: 1883-6.
Bigio I, Bown S, Briggs G, et al. Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results.J Biomed Opt2000; 5: 221-8.
Mourant JR, Bigio I, Boyer J, Conn R, Johnson TM, Shimada T. Spectroscopic diagnosis of bladder cancer with elastic scattering spectroscopy.Lasers Surg Med1995; 17: 350-7.
Mourant JR, Bigio I, Boyer J, Johnson TM, Lacey J. Elastic scattering spectroscopy as a diagnostic for differentiating pathologies in the gastrointestinal tract: preliminary testing.J Biomed Opt1996; 1: 1-8.
Sokolov K, Drezek R, Gossage K, Richards-Kortum R. Reflectance spectroscopy with polarized light: is it sensitive to cellular and nuclear morphology?Opt Express1999; 5: 302-17.
Georgakoudi I, Sheets EE, Muller MG, et al. Tri-Modal Spectroscopy for the detection and characterization of cervical pre-cancers in vivo.Am J Obstet Gynecol2002; 186: 374-82.
Georgakoudi I, Jacobson B, Van Dam J, et al. Fluorescence, reflectance and light scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus.Gastroenterol2001; 120: 1620-9.
Mourant JR, Canpolat M, Brocker C, et al. Light scattering from cells: the contribution of the nucleus and the effects of proli
Georgakoudi Irene
Lin Charles P.
Geary III William C.
Gitomer Ralph
Mollaaghababa Reza
Nutter & McClennen & Fish LLP
Shen Bin
LandOfFree
Methods of in vivo cytometry does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of in vivo cytometry, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of in vivo cytometry will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3798214